SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $59,446,052 | -28.2% | 2,571,196 | -18.5% | 0.00% | -25.0% |
Q2 2023 | $82,738,547 | +14.3% | 3,155,551 | +12.2% | 0.00% | 0.0% |
Q1 2023 | $72,362,116 | -63.0% | 2,811,271 | -62.6% | 0.00% | -33.3% |
Q4 2022 | $195,370,942 | +106.0% | 7,511,378 | +126.0% | 0.01% | 0.0% |
Q3 2022 | $94,835,000 | -1.0% | 3,324,062 | -14.5% | 0.01% | 0.0% |
Q2 2022 | $95,753,000 | +6.3% | 3,889,249 | +143.7% | 0.01% | +50.0% |
Q1 2022 | $90,072,000 | +10.2% | 1,595,890 | +21.0% | 0.00% | 0.0% |
Q4 2021 | $81,758,000 | -3.1% | 1,319,111 | -0.8% | 0.00% | 0.0% |
Q3 2021 | $84,338,000 | -5.4% | 1,329,418 | +22.9% | 0.00% | -20.0% |
Q2 2021 | $89,161,000 | +12.3% | 1,081,921 | +0.2% | 0.01% | 0.0% |
Q1 2021 | $79,424,000 | +1.6% | 1,079,568 | +0.1% | 0.01% | 0.0% |
Q4 2020 | $78,173,000 | +105.8% | 1,077,952 | +35.3% | 0.01% | +66.7% |
Q3 2020 | $37,985,000 | +140.8% | 796,842 | +112.2% | 0.00% | +200.0% |
Q2 2020 | $15,773,000 | +236.9% | 375,536 | +116.5% | 0.00% | – |
Q1 2020 | $4,682,000 | -16.3% | 173,419 | +19.4% | 0.00% | – |
Q4 2019 | $5,591,000 | – | 145,253 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |